🇺🇸 FDA
Pipeline program

1mg elsunersen

PRAX-222-311

Phase 3 small_molecule active

Quick answer

1mg elsunersen for Epileptic Encephalopathy is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Epileptic Encephalopathy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials